Evidence map›Paper›PMID 28583187›Full record

ArticleBMC research notes2017

Antimicrobial susceptibility pattern of Shigella spp. isolated from children under 5 years of age attending tertiary care hospitals, Nepal along with first finding of ESBL-production.

Subhash Dhital, Jeevan Bahadur Sherchand, Bharat Mani Pokharel, Keshab Parajuli, Shyam Kumar Mishra, Sangita Sharma, Hari Prasad Kattel, Sundar Khadka, Sulochana Khatiwada, Basista Rijal

Open access · goldAbstract read
In one paragraph

Article in BMC research notes, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Antimicrobial Susceptibility Patterns ofThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2023
    Article
  5. Article
  6. Review
  7. Article
  8. Immunomodulatory Effects of Asiaticoside AgainstTropical life sciences research · 2021
    Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Subhash DhitalNational Public Health Laboratory, HIV Reference Unit, Kathmandu, Nepal. dhital.subhash@iom.edu.np.ORCID http://orcid.org/0000-0003-3432-9085
Jeevan Bahadur SherchandDepartment of Microbiology, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.
Bharat Mani PokharelDepartment of Microbiology, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.
Keshab ParajuliDepartment of Microbiology, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.
Shyam Kumar MishraDepartment of Microbiology, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.
Sangita SharmaDepartment of Microbiology, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.
Hari Prasad KattelDepartment of Microbiology, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.
Sundar KhadkaNational Public Health Laboratory, HIV Reference Unit, Kathmandu, Nepal.
Sulochana KhatiwadaDepartment of Microbiology, Universal Medical College, Bhairahawa, Nepal.
Basista RijalDepartment of Microbiology, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.
Tribhuvan University Teaching Hospital · NPNational Public Health Laboratory · NPCollege of Medical Sciences · NP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundShigella is an important cause of bacterial gastroenteritis in resource-poor countries. The treatment of shigellosis mostly requires antibiotics. However, the increase of multidrug resistance along with emergence of extended-spectrum β-lactamase and ciprofloxacin resistance among Shigella spp. has challenged the situation. This study was conducted to determine the distribution of species and antibiotic susceptibility pattern of Shigella species isolated from stool specimen among children less than 5 years of age in Nepal.

resultsOut of total 717 stool samples collected, 15 cases of Shigella spp. was isolated which includes 12 S. flexneri and 3 S. sonnei. Multidrug resistance was found among 13(86%) of the isolates. One of the isolates of S. flexneri was found to be ESBL-producer with MIC >256 mg/L for cefixime.

conclusionThe high occurrence of multidrug resistance among Shigella spp. along with a case of ESBL-production for the first time in Nepal alarms the concerns about dissemination of the resistant isolates. So, systemic monitoring of the antimicrobial susceptibility pattern of Shigella spp. is becoming crucial to guide therapy.

Indexed as

Tertiary Care CentersAnti-Infective Agentsbeta-LactamasesCefiximeChildChild, PreschoolCiprofloxacinDrug Resistance, MultipleDysentery, BacillaryFecesHumansInfantMicrobial Sensitivity TestsNepalShigellaAnti-Infective Agentsbeta-LactamasesCefiximeCiprofloxacinAntibiotic resistanceESBLNepalShigella

Identifiers

PMID28583187
PMCPMC5460519
OpenAlexW2624421651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.